The COVID 19 pandemic took the world by storm and has left hundreds of thousands of people depressed. They are no longer in touch with their mental health and inner wellness. These are two situations, Mydecine Innovations Group Inc. (OTCMKTS: MYCOF) is seeking to support through its subsidiary Mindleap Health. The virtual healthcare subsidiary offers technology solutions, which allow people to improve their mental health and wellbeing. It features an ever-expanding content library, a private health journal, and a community of professionals.
As the infrastructure of supporting mental health expands, Mydecine has announced the launch of the 2.0 version by its subsidiary. This is a form of a virtual health platform that supports the conscious and trustworthy adoption of psychedelics into the broader wellness categories. Additionally, it focuses on the community, allowing users to know and learn from mental health experts through media and written posts. The provision of private video support calls helps the users integrate with professionals as they share their health journals.
Developing a Better Understanding and Paving the way for the Future of Mental Health
Mydecine Innovations Group is on record for developing and commercializing innovative solutions for treating mental health problems. The emerging biotech and life sciences company has gained acceptance in the medical community to demonstrate its remarkable clinical effectiveness and enhance vitality.
On the other hand, Mindleap recognizes the responsibility associated with assisting people with their daily mental-health journey. By implementing patient care and monitoring clinical trials, the company also acknowledges a need for advancing bundled solutions, which pave the way for the future of mental health.
“We are providing a platform that can help transform the lives of millions of people,” Mindleap Interim CEO William Cook professed. “Our aim is to bring conscious and trustworthy support for people on their daily mental-health journey while also supporting life-changing healing experiences.”
And as all this unfolds, Mydecine continues to pursue its passion and mission of developing high-quality products and disruptive new technologies, the aim being to make the world a better place.
The Green Organic Dutchman Holdings (OTC: TGODF) Releases an Update on its Canadian Securities Exchange Listing
Post Views: 4 The Green Organic Dutchman Holdings (OTC: TGODF) is a top producer of organically-grown, premium certified marijuana, and it...
Next Green Wave Holdings Inc (OTCMKTS: NXGWF) Announces the Resignation of One of Its Directors
Post Views: 55 Next Green Wave Holdings Inc (OTCMKTS: NXGWF) recently announced that a Director had resigned from this position. The...
AFC Gamma Inc (NASDAQ: AFCG) Increases Quarterly Dividend by 13.2% per Share, and the Group Expands its Senior Secured Credit Facility with Devi Holdings, Inc. by $30 Million
Post Views: 26 AFC Gamma Inc (NASDAQ: AFCG) recently announced a dividend for the quarter ending September 30, 2021. The...
TerrAscend Corp (OTCMKTS: TRSSF) Acquisition of Gage Cannabis Receives Pre-Qualification Approval
Post Views: 53 TerrAscend Corp (OTCMKTS: TRSSF) is a leading cannabis operator based in North America that recently announced it had...
Jushi Holdings Inc (OTCMKTS: JUSHF) Opens 15th Store in Pennsylvania, Acquires Nature’s Remedy, and Announced Launch of Flower Brands
Post Views: 2 Jushi Holdings Inc (OTCMKTS: JUSHF), through its subsidiary, Franklin Bioscience – SE LLC. BEYOND / HELLO™ Colwyn...
FinCanna Capital Corp (OTCMKTS: FNNZF) Set to launch its “Big Fish” Cannabis-Based Edibles Brand
Post Views: 3 FinCanna Capital Corp (OTCMKTS: FNNZF) is an investment corporation for the United States licensed cannabis market that recently...